{"id":"https://openalex.org/W4394765670","doi":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.01.016","title":"[Short-term Effect of Venetoclax Combined with Azacitidine and \"7+3\" Regimen in the Treatment of Newly Diagnosed Elder Patients with Acute Myeloid Leukemia].","display_name":"[Short-term Effect of Venetoclax Combined with Azacitidine and \"7+3\" Regimen in the Treatment of Newly Diagnosed Elder Patients with Acute Myeloid Leukemia].","publication_year":2024,"publication_date":"2024-02-01","ids":{"openalex":"https://openalex.org/W4394765670","doi":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.01.016","pmid":"https://pubmed.ncbi.nlm.nih.gov/38387906"},"language":"zh","primary_location":{"id":"pmid:38387906","doi":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.01.016","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38387906","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhongguo shi yan xue ye xue za zhi","raw_type":"English Abstract"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062454495","display_name":"Xiaxia Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17721919","display_name":"Shanxi Medical University","ror":"https://ror.org/0265d1010","country_code":"CN","type":"education","lineage":["https://openalex.org/I17721919"]},{"id":"https://openalex.org/I4210133678","display_name":"Second Hospital of Shanxi Medical University","ror":"https://ror.org/03tn5kh37","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133678"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xia-Xia Liu","raw_affiliation_strings":["Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China","institution_ids":["https://openalex.org/I17721919","https://openalex.org/I4210133678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032632875","display_name":"Xiaoling Wen","orcid":"https://orcid.org/0000-0001-7300-4027","observed_orcids":["https://orcid.org/0000-0001-7300-4027"]},"institutions":[{"id":"https://openalex.org/I17721919","display_name":"Shanxi Medical University","ror":"https://ror.org/0265d1010","country_code":"CN","type":"education","lineage":["https://openalex.org/I17721919"]},{"id":"https://openalex.org/I4210133678","display_name":"Second Hospital of Shanxi Medical University","ror":"https://ror.org/03tn5kh37","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133678"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiao-Ling Wen","raw_affiliation_strings":["Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China","institution_ids":["https://openalex.org/I17721919","https://openalex.org/I4210133678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054458341","display_name":"Ruo-Qi Li","orcid":"https://orcid.org/0009-0008-1061-5347","observed_orcids":["https://orcid.org/0009-0008-1061-5347"]},"institutions":[{"id":"https://openalex.org/I17721919","display_name":"Shanxi Medical University","ror":"https://ror.org/0265d1010","country_code":"CN","type":"education","lineage":["https://openalex.org/I17721919"]},{"id":"https://openalex.org/I4210133678","display_name":"Second Hospital of Shanxi Medical University","ror":"https://ror.org/03tn5kh37","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133678"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ruo-Qi Li","raw_affiliation_strings":["Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China","institution_ids":["https://openalex.org/I17721919","https://openalex.org/I4210133678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011191653","display_name":"Xia-Lin Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17721919","display_name":"Shanxi Medical University","ror":"https://ror.org/0265d1010","country_code":"CN","type":"education","lineage":["https://openalex.org/I17721919"]},{"id":"https://openalex.org/I4210158804","display_name":"Shanxi Academy of Medical Sciences","ror":"https://ror.org/04tshhm50","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xia-Lin Zhang","raw_affiliation_strings":["Department of Hematology,The Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, Shanxi Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology,The Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, Shanxi Province, China","institution_ids":["https://openalex.org/I17721919","https://openalex.org/I4210158804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049986299","display_name":"Tian-Bo Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17721919","display_name":"Shanxi Medical University","ror":"https://ror.org/0265d1010","country_code":"CN","type":"education","lineage":["https://openalex.org/I17721919"]},{"id":"https://openalex.org/I4210158804","display_name":"Shanxi Academy of Medical Sciences","ror":"https://ror.org/04tshhm50","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tian-Bo Zhang","raw_affiliation_strings":["Department of Hematology,The Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, Shanxi Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology,The Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, Shanxi Province, China","institution_ids":["https://openalex.org/I17721919","https://openalex.org/I4210158804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101237494","display_name":"Chunxia Dong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17721919","display_name":"Shanxi Medical University","ror":"https://ror.org/0265d1010","country_code":"CN","type":"education","lineage":["https://openalex.org/I17721919"]},{"id":"https://openalex.org/I4210133678","display_name":"Second Hospital of Shanxi Medical University","ror":"https://ror.org/03tn5kh37","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133678"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chun-Xia Dong","raw_affiliation_strings":["Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China","institution_ids":["https://openalex.org/I17721919","https://openalex.org/I4210133678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100771912","display_name":"Meifang Wang","orcid":"https://orcid.org/0000-0002-8876-6857","observed_orcids":["https://orcid.org/0000-0002-8876-6857"]},"institutions":[{"id":"https://openalex.org/I17721919","display_name":"Shanxi Medical University","ror":"https://ror.org/0265d1010","country_code":"CN","type":"education","lineage":["https://openalex.org/I17721919"]},{"id":"https://openalex.org/I4210133678","display_name":"Second Hospital of Shanxi Medical University","ror":"https://ror.org/03tn5kh37","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133678"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mei-Fang Wang","raw_affiliation_strings":["Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China","institution_ids":["https://openalex.org/I17721919","https://openalex.org/I4210133678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100434757","display_name":"Jianhua Zhang","orcid":"https://orcid.org/0000-0001-7833-9715","observed_orcids":["https://orcid.org/0000-0001-7833-9715"]},"institutions":[{"id":"https://openalex.org/I17721919","display_name":"Shanxi Medical University","ror":"https://ror.org/0265d1010","country_code":"CN","type":"education","lineage":["https://openalex.org/I17721919"]},{"id":"https://openalex.org/I4210133678","display_name":"Second Hospital of Shanxi Medical University","ror":"https://ror.org/03tn5kh37","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133678"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jian-Hua Zhang","raw_affiliation_strings":["Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China","institution_ids":["https://openalex.org/I17721919","https://openalex.org/I4210133678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100574670","display_name":"Linhua Yang","orcid":"https://orcid.org/0000-0001-9020-9446","observed_orcids":["https://orcid.org/0000-0001-9020-9446"]},"institutions":[{"id":"https://openalex.org/I17721919","display_name":"Shanxi Medical University","ror":"https://ror.org/0265d1010","country_code":"CN","type":"education","lineage":["https://openalex.org/I17721919"]},{"id":"https://openalex.org/I4210133678","display_name":"Second Hospital of Shanxi Medical University","ror":"https://ror.org/03tn5kh37","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133678"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lin-Hua Yang","raw_affiliation_strings":["Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China","institution_ids":["https://openalex.org/I17721919","https://openalex.org/I4210133678"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088453685","display_name":"Ruijuan Zhang","orcid":"https://orcid.org/0000-0003-1147-9240","observed_orcids":["https://orcid.org/0000-0003-1147-9240"]},"institutions":[{"id":"https://openalex.org/I17721919","display_name":"Shanxi Medical University","ror":"https://ror.org/0265d1010","country_code":"CN","type":"education","lineage":["https://openalex.org/I17721919"]},{"id":"https://openalex.org/I4210158804","display_name":"Shanxi Academy of Medical Sciences","ror":"https://ror.org/04tshhm50","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Rui-Juan Zhang","raw_affiliation_strings":["Department of Hematology,The Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, Shanxi Province, China .E-mail: 13593169668@163.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology,The Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, Shanxi Province, China .E-mail: 13593169668@163.com","institution_ids":["https://openalex.org/I17721919","https://openalex.org/I4210158804"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2883,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.52619483,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":"32","issue":"1","first_page":"96","last_page":"103"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.8669999837875366},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":1.0},{"id":"https://openalex.org/keywords/7-3-regimen","display_name":"7+3 regimen","score":0.8309999704360962},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9950000047683716},{"id":"https://openalex.org/keywords/newly-diagnosed-aml","display_name":"newly diagnosed AML","score":0.878000020980835},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7480000257492065},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/infection-incidence","display_name":"infection incidence","score":0.5519999861717224},{"id":"https://openalex.org/keywords/7q-deletion","display_name":"7q deletion","score":0.7229999899864197},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7879999876022339},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7983486652374268},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7336229681968689},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.7102108001708984},{"id":"https://openalex.org/C9583187","wikidata":"https://www.wikidata.org/wiki/Q7919510","display_name":"Ven","level":2,"score":0.6104341745376587},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5907780528068542},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5715328454971313},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5446916818618774},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5119096040725708},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.4748026430606842},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.42405933141708374},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.34262803196907043},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.11639571189880371},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002869","descriptor_name":"Chromosome Aberrations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:38387906","doi":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.01.016","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38387906","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhongguo shi yan xue ye xue za zhi","raw_type":"English Abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4412047237","https://openalex.org/W4389664949","https://openalex.org/W4400410926","https://openalex.org/W7204260485","https://openalex.org/W7204598165","https://openalex.org/W2889570799","https://openalex.org/W7133560384","https://openalex.org/W3195918910","https://openalex.org/W4245397140","https://openalex.org/W4210396887"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"the":[3,36,48,56,94,118],"short-term":[4,103],"effect":[5,104],"and":[6,55,68,90,108],"adverse":[7,91],"reaction":[8],"of":[9,39,51,105,125,129],"venetoclax":[10],"(VEN)":[11],"combined":[12],"with":[13,24,45,144],"azacitidine":[14],"(AZA)":[15],"versus":[16],"\"7+3\"":[17,69,109],"regimen":[18,120],"in":[19,111],"newly":[20,41],"diagnosed":[21,42],"elder":[22,43],"patients":[23,44,114,142],"acute":[25],"myeloid":[26],"leukemia":[27],"(AML).":[28],"METHODS:":[29],"From":[30],"January":[31,34],"2021":[32],"to":[33,80],"2022,":[35],"clinical":[37],"data":[38],"seventy-nine":[40],"AML":[46,113,141],"at":[47],"Second":[49],"Hospital":[50,59],"Shanxi":[52,57],"Medical":[53],"University":[54],"Bethune":[58],"were":[60,97],"retrospectively":[61],"analyzed,":[62],"including":[63],"VEN+AZA":[64,106,119],"group":[65,70,107],"(41":[66],"cases)":[67],"(38":[71],"cases).":[72],"The":[73,102,127],"propensity":[74],"score":[75],"matching(PSM)":[76],"method":[77],"was":[78],"used":[79],"balance":[81],"confounding":[82],"factors\uff0c":[83],"then":[84],"response\uff0c":[85],"overall":[86],"survival(OS),":[87],"progression\ue011free":[88],"survival(PFS)":[89],"reactions":[92],"between":[93],"two":[95],"groups":[96],"compared.":[98],"RESULTS:":[99],"=0.048).":[100],"CONCLUSION:":[101],"regimens":[110],"eldrly":[112],"are":[115],"similar\uff0c":[116],"but":[117],"had":[121],"a":[122,135],"lower":[123],"incidence":[124],"infection.":[126],"presence":[128],"chromosome":[130],"7":[131],"abnormality\uff087q-/-7\uff09":[132],"may":[133],"be":[134],"poor":[136],"prognostic":[137],"factor":[138],"for":[139],"elderly":[140],"treated":[143],"VEN+AZA.":[145]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-04-13T00:00:00"}